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ÖZ
Amaç: Bu çalışma protokateşuik asit (PCA) ve 5-florourasilin (5-FU) gastrik adenokarsinoma (AGS) hücreleri üzerine kombine etkisini 
değerlendirmiştir.
Gereç ve Yöntemler: 3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolium bromid yöntemi, koloni oluşturma yöntemi, akış sitometrisi tekniği, gerçek 
zamanlı kantitatif polimeraz zincir reaksiyonu ve Western blot yöntemleri 5-FU ve PCA’ya maruz kalan AGS hücrelerinde sitotoksisite, koloni 
oluşumu, apoptoz, p53 gen ekspresyonu ve  Bcl-2 düzeylerini belirlemek için kullanılmıştır. 
Bulgular: Sonuçlarımız PCA’nın tek başına (500 µM) veya 5-FU (10 µM) ile kombinasyonunun uygulama yapılmamış kontrol hücrelerine göre 
AGS hücre proliferasyonunu ve koloni oluşturmunu inhibe ettiğini ve apoptozu artırdığını göstermiştir. Ek olarak, uygulama yapılmamış kontrol 
hücrelerine göre kombine 5-FU/PCA maruziyeti p53 düzeylerini artırmış ve Bcl-2 düzeylerini artırmıştır.
Sonuç: Sonuçlar göstermiştir ki AGS hücrelerinde kombine 5-FU/PCA maruziyeti koloni oluşumunu inhibe ederek antiproliferatif ve pro-apoptotik 
etkiler başlatabilir. Kombine 5-FU/PCA maruziyetinin etki gösterme mekanizması p53 geninin artması ve Bcl-2 geninin azalması ile ilişkili olabilir. 
ABSTRACT
Objectives: This study evaluated the combined effects of protocatechuic acid (PCA) and 5-fluorouracil (5-FU) on gastric adenocarcinoma (AGS) 
cells. 
Materials and Methods: The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, colony formation assay, flow cytometry technique, 
real-time quantitative polymerase chain reaction, and Western blotting were used to investigate cytotoxic effects, colony formation, apoptosis, p53 
gene expression, and Bcl-2 protein level in AGS cells treated with 5-FU and PCA.
Results: Our results demonstrated that PCA (500 µM) alone or in combination with 5-FU (10 µM) inhibited AGS cell proliferation, inhibited a colony 
formation, and increased apoptosis compared with untreated control cells. Moreover, the combined 5-FU/PCA exposure led to upregulation of p53 
and downregulation of Bcl-2 protein when compared to the untreated control cells.
Conclusion: The results demonstrate that the combined 5-FU/PCA may promote antiproliferative and pro-apoptotic effects with the inhibition of 
colony formation in AGS cells. The mechanisms by which the combined 5-FU/PCA exposure exerts its effects are associated with upregulation of 
p53 gene expression and downregulation of Bcl-2 level. Therefore, the combination of 5-FU with PCA not only could be a promising approach to 
potentially reduce the dose requirements of 5-FU but also could promote apoptosis via p53 and Bcl-2 signaling pathways. 
Key words: Apoptosis, 5-fluorouracil, protocatechuic acid, gastric cancer, combination, colony formation 
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INTRODUCTION 
Gastric cancer figures worldwide among the major issues faced 
by health systems due to its incidence and mortality rate. The 
5-year survival rate for this disease is only about 20%.1 Gastric 
cancer’s prevalence varies in different geographic regions.2 
Gastric cancer can be affected by predisposing factors to 
gastric carcinoma encompassing familial genetic background, 
smoking, inadequate intake of antioxidants, disproportionate salt 
intake, and infection by H. pylori. Furthermore, disorders such 
as gastritis, intestinal metaplasia, dysplasia, paraneoplastic 
lesions, and chronic atrophic gastritis are among the underlying 
causes of gastric cancer.2
The therapeutic options for gastric carcinoma are primarily 
surgery, radiotherapy, and chemotherapy.3 5-fluorouracil (5-
FU) is a heterocyclic aromatic anticancer chemical agent that is 
widely used to handle various cancers by inhibiting the enzyme 
thymidylate synthase, preventing DNA replication.4,5 However, 
5-FU has many side effects (diarrhea, stomatitis, emesis, 
neutropenia, inflammation of the mouth, loss of appetite, low 
blood cell counts, hair loss, and skin inflammation).6 Moreover, 
administration of 5-FU is frequently limited by dose-limiting 
toxicities. Interaction of chemotherapy with natural compounds 
may present a new perspective and an innovative strategy in 
cancer therapy. Interestingly, herbal compounds in tandem 
with 5-FU amplify the synergistic effects of administered 
therapeutics and exert cytotoxic effects specifically in tumor 
cells. Combined therapy with synergistic effects not only 
reduces the drug doses and resistance in chemotherapy but also 
decreases metastasis, raises the efficacy of 5-FU, and induces 
apoptosis.7 Apoptosis in cells is a type of programmed cell 
death under the control of factors such as p53 gene expression, 
which is mutated in most cancer cells. This gene plays a 
crucial role in genome stability, tumor suppression, induction 
of apoptosis, cell cycle stopping, and aging.8 In addition, p53 
acts as a transcription factor for pre-apoptotic proteins.9 
Various experiments have been conducted to discover and 
use natural compounds for induction of apoptosis in cancer 
cells. Epidemiological studies have shown that a diet rich in 
phytochemical compounds is effective in inducing apoptosis 
in some cancers.1,10 Phytochemicals with antioxidant activity 
can inhibit carcinogenic processes in several models due 
to the expression of key proteins in signal transduction 
pathways and induction of apoptosis.11 It is also reported 
that many polyphenols can reduce the adverse effects of 
chemical therapies.1 Protocatechuic acid (PCA), also known 
as 3,4-dihydroxybenzoic acid, is a herbal phenolic acid mainly 
present in fruits, vegetables, and nuts and has anti-inflammatory, 
antibacterial, antihyperglycemic, anticancer, antiulcer, and 
antispasmodic properties.12-14 Therefore, the aim of the present 
study was to assess the combined effects of 5-FU and PCA 
on p53 gene expression, colony formation, apoptosis, and Bcl-
2 signaling protein level in the gastric adenocarcinoma (AGS) 
cell line.
MATERIALS AND METHODS 
Chemicals and antibodies
The investigated human AGS cells were procured from the 
Pasteur Institute (Tehran, Iran). RPMI 1640 medium, trypsin 
0.25%, penicillin/streptomycin (pen/strep), and fetal bovine 
serum (FBS) were supplied by Gibco (Rockville, MD, USA). 
Bcl-2 and β-actin primary antibodies were purchased from 
Elabscience Biotechnology Co. (Wuhan, China). PCA and 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) were obtained from Sigma-Aldrich (St. Louis, MO, USA). 
5-FU was purchased from Haupt Pharma (Wolfratshausen 
GmbH Co, Germany). The Roti®ZOL total RNA extraction kit was 
obtained from Carl Roth GmbH, Germany. The Annexin V-PI 
staining kit was purchased from BD Bioscience (California, 
USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
and p53 primers were purchased from Macrogen Company 
(South Korea). The other reagents used were of analytical 
grade. 
Cell viability assay
AGS cells were cultured in 96-well plates (5000 cells per 
well) overnight in RPMI 1640 medium that contained 10% 
FBS and 1% pen/strep at 37°C in 98% humidity with 5% CO2. 
Subsequently, the cells were treated with 5-FU (0-55 µM), PCA 
(0-1100 µM, solution in dimethyl sulfoxide (DMSO) with 0.1% 
final concentration), and the combination of 5-FU with PCA 
(10 µM and 500 µM, respectively) for 24 h. Then the medium 
was removed and the cells were incubated with MTT solution 
(5 mg/mL) for 4 h at 37°C. Afterwards, DMSO was added to 
each well of 96-well plates. The absorbance of each well was 
measured with a microplate reader (Stat Fax-2100, USA) at 
490-570 nm. The percentage of cell viability was assessed as 
follows: viability=A (sample)/A (control)x100.15 At least three 
independent experiments were carried out.
Assessing the synergistic effects of 5-FU and PCA
The IC50 values of 5-FU and PCA were used to determine 
synergistic effects between 5-FU and PCA through the 
combination index (CI) using the CI equation:16 CI=A/A50+B/B50, 
where A related to 5-FU concentration in combination with B, 
and B depicting PCA concentration in combination with A. A50 
is the IC50 of 5-FU and the B50 is the IC50 of PCA. A CI value of 1 
represents an additive effect, CI <1 indicates synergism, and CI 
>1 represents antagonism.17 Therefore, a combination of 5-FU 
(10 µM, IC20) and PCA (500 µM, IC30) was used based on the 
results of the MTT assay.
Bu nedenle, 5-FU’nun PCA ile birlikte kombinasyonu 5-FU’nun doz rejimlerinin azaltılmasında potansiyel olarak umut verici bir yaklaşım olurken, 
aynı zamanda p53 ve Bcl-2 sinyalleşme yolaklarıyla apoptozu başlatabilir. 
Anahtar kelimeler: Apoptoz, 5-florourasil, protokateşuik asit, mide kanseri, kombinasyon, koloni oluşumu
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Colony formation assay
For the colony formation assay, AGS cells were cultured in 
6-well plates (3x105 cells per well) overnight. The cells were 
then treated with 5-FU alone (10 µM), PCA alone (500 µM), 
and the combination of 5-FU and PCA (10 µM and 500 µM, 
respectively) and incubated at 37°C in an atmosphere of 5% CO2 
for 24 h. Then the medium was removed, while the cell culture 
medium was changed every 2 days for 14 days. Subsequently, 
the cells were washed with PBS and fixed with 70% ethanol 
and colonies were stained with 0.5% crystal violet. The number 
of colonies was counted and plating efficiency (PE) was 
calculated by the following formula: PE=(number of colonies/
number of seeded cells) x100 and surviving fraction (SF) was 
determined by SF=(number of colonies/number of seeded cells 
x PE control) x100.18
Apoptosis detection assay 
The percentage of apoptosis and necrosis of cells were determined 
through flow cytometry using the AnnexinV-FITC Apoptosis 
Detection Kit (BD Bioscience, Franklin Lakes, NJ, USA). Briefly, 
AGS cells (2x105 per well) were cultured in 6-well plates and 
incubated overnight. The cells were treated with 5-FU (10 µM) 
and PCA (500 µM) or a combination of 5-FU and PCA (10 µM and 
500 µM, respectively) for 24 h. Then the cells were harvested by 
trypsinization, washed with PBS, and stained with Annexin V for 20 
min according to the manufacture’s protocol at room temperature 
in the dark.19 The cells were analyzed using a FACScan system 
(Becton-Dickinson and Company, San Jose, CA, USA).
Reverse transcription-quantitative polymerase chain reaction 
(RT-qPCR)
RT-qPCR was then applied so as to assess the p53 gene 
expression in AGS cells. In summary, total RNA from each of the 
untreated control cells, 5-FU (10 µM), and PCA (500 µM) or the 
combination of 5-FU and PCA (10 µM and 500 µM, respectively) 
was extracted after 24 h of treatment using Roti®ZOL solution 
according to the manufacturer’s instructions. The total 
mRNA concentration and quality of RNA were evaluated by 
OD measurements at 260/280 ratio using a Nanodrop 2000 
spectrophotometer (Thermo-USA). For cDNA synthesis 1 µg 
of RNA was used with a synthesis kit (Takara Bio Inc., Japan) 
according to the manufacturer’s instructions and stored at -20°C 
for subsequent use. The procedure of cDNA RT was applied 
using a Prime ScriptTM Reagent Kit (Takara Bio Inc., Japan) 
according to the manufacturer’s instructions. Then cDNA was 
expanded by RT-qPCR using SYBR® Green PCR Master Mix 
(Takara Bio Inc., Japan) in the presence of specific primers. 
The sequences of the primers for the reaction were as follows: 
H-p53-F, forward 5’-CCCATCCTCACCATCATCACAC-3’ and 
reverse 5’-GCACAAACACGCACCTCAAAG3’ and H-GAPDH-F, 
forward 5’ACACCCACTCCTCCACCCTTTG3’, and reverse 
5’GTCCACCACCCTGTTGCTGTA-3’. The primers were prepared 
with Oligo 6.0 software (Molecular Biology Insights, Cascade, 
CO, USA) and confirmed by BLAST (NCBI). The GAPDH gene 
was used as a reference gene for normalization. Enzyme 
activation was conducted for 10 min at 95°C, followed by 40 
cycles of initial denaturation at 95°C for 10 s and annealing/
extension at 62°C for 15 s and melting at 72°C for 20 s in a 3000 
Rotor Gene (Corbett, Australia) real-time PCR system.20
Western blotting
The AGS cells were grown in 6-cm dishes at the density 
of 6x105. After 24 h of treatment, protein extraction were 
performed for the control, 5-FU (10 µM), PCA (500 µM), and the 
combination of 5-FU and PCA (10 µM and 500 µM, respectively) 
using RIPA lysis buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 
1% Triton X-100, 1 mmol/L sodium orthovanadate, 0.5% sodium 
deoxycholate, 50 mmol/L NaF, 0.1% SDS, 1 mM EDTA, 0.1% 
sodium azide, 1 mmol/L phenylmethylsulfonyl fluoride, 50 
µL of protease, and 250 µL of phosphatase inhibitor).21 The 
supernatants were collected and protein concentrations were 
determined using Bradford’s procedure.22 The Western blot 
procedure was described previously21 and primary antibodies 
Bcl-2 and β-actin were used according to the manufacturer’s 
protocols. β-actin was determined as an internal control. Then 
the blots were washed with TBS-Tween buffer 3 times for 10 
min and they were incubated with horseradish peroxidase-
conjugated secondary antibody at room temperature for 2 
h and washed again as described above. Band intensity was 
evaluated using chemiluminescent reagents (ECL; Thermo 
Fisher Scientific, USA) and analyzed using ImageJ software.20
Statistical analysis
The results of all experiments were expressed as mean ± 
standard deviation and the experiments were performed at least 
three times. SPSS (Version 20, SPSS Inc., Chicago, IL, USA) or 
GraphPad Prism 6 (Graphpad Software, San Diego, CA, USA) 
was used to perform the statistical analysis. Kruskal-Wallis 
analyses were used to assess between-group differences for 
the MTT assay, clonogenic assay, Annexin V assay, and RT-
PCR. For expression analysis, the relative levels of quantitative 
gene expression were calculated by the 2-∆∆Ct method and the 
data were expressed as fold change. Melting curve analysis 
was performed after amplification to verify product identity. 
Western blotting was repeated 3 times. P values less than 0.05 
were considered statistically significant for the differences 
between the groups. The CI was calculated using experimental 
CompuSyn software (ComboSyn Inc, Paramus, NJ, USA), 
and CI ˂1, =1, and ˃1 indicated synergism, additive effect, and 
antagonism, respectively. 
RESULTS
Effects of 5-FU, PCA, and their combination on AGS cell 
viability 
The result of the MTT assay demonstrated that 5-FU, PCA, and 
their combination can reduce the proliferation of AGS cells 
after 24 h (Figure 1). The IC50 values of 5-FU and PCA alone 
were 40 µM and 700 µM, respectively (Figures 1A and 1B). The 
combination of 5-FU and PCA (10 µM and 500 µM, respectively) 
led to a synergistic CI equal to 0.6 with strong effects on AGS 
cell proliferation (Table 1). Moreover, the number of living cells 
decreased in the combination of 5-FU with PCA (10 µM and 500 
µM, respectively) relative to untreated control cells and each 
agent alone (Figure 1C). 
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Clonogenic assay of AGS cells 
The results of the colony formation assay demonstrated that the 
combination of 5-FU with PCA (10 µM and 500 µM, respectively) 
significantly decreased the colony numbers of AGS cells and 
the proliferation rate compared with those of the untreated 
control cells and 5-FU treated cells (Figure 2). After 14 days 
of cell culture, the number of colonies consisted of 63, 46, 30, 
and 22 for the control, 5-FU, PCA, and 5-FU/PCA combinations, 
respectively (Figure 2B). The SF for 5-FU, PCA, and 5-FU/PCA 
combination were 71%, 49%, and 34%, respectively. The results 
also showed PE in the control and treated experimental cells 
(Figure 2A). 
Effects of 5-FU and PCA on apoptosis
The results of the flow cytometry showed the percentage 
of apoptosis and necrosis of 5-FU and PCA in AGS cells 
(Figure 3). Apoptosis in AGS cells was induced 17% by 10 µM 
5-FU, 23% by 500 µM PCA, and 27% by the combination of 
5-FU and PCA (10 µM and 500 µM, respectively). Apoptosis 
significantly increased (p<0.05) in the combination of 5-FU and 
PCA treatment when compared to that of the control and 5-FU 
treated cells (Figure 3).
Expression of p53 in AGS cells 
The results of RT-qPCR showed p53 gene expression in the 
combination of 5-FU and PCA (10 µM and 500 µM, respectively). 
PCA and the 5-FU/PCA combination led to a significant increase 
(p<0.05) in p53 gene expression by almost 5.5- and 11.6- fold, 
respectively, in comparison with the control cells (Figure 4). No 
significant change was observed between 5-FU and untreated 
control cells.
Effects of 5-FU, PCA, and 5-FU/PCA combination on Bcl-2 
signaling protein in AGS cells 
The result of Western blotting demonstrated that the protein 
expression level of Bcl-2 markedly decreased after treatment 
with the 5-FU/PCA combination in AGS cells when compared 
to that of the untreated control cells and 5-FU treated cells 
(Figure 5).
DISCUSSION
The prevalence of cancer is increasing worldwide and 
the growing rate of mortality is quite alarming. Nowadays, 
5-FU-based chemotherapy is a widespread procedure in 
the treatment of a wide range of cancers, including gastric, 
colorectal, and breast cancers, due to its effect in the inhibition 
of thymidylate synthase.23,24 Combination therapy not only 
Figure 1. Inhibition of cell proliferation by 5-FU (A) and PCA (B) for 24 h. 
The cells were cultured at the density of 5x103 cells per well for 24 h. At 
the end of treatment time, cell viability was measured by MTT assay. Data 
are expressed as mean ± SD of 3 independent experiments. Also Figure 1C 
demonstrates cell morphological changes in AGS cells after treatment with 
5-FU, PCA, and their combination. 1C-a: control, 1C-b: 5-FU, 1C-c: PCA, 
1C-d: 5-FU plus PCA
5-FU: 5-fluorouracil, PCA: Protocatechuic acid, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, SD: Standard deviation, AGS: Gastric adenocarcinoma Figure 2. Colonies produced by the AGS cell line in the absence or 
presence of 5-FU, PCA, and 5-FU/PCA combination. (A): Histogram plot 
demonstrates plating efficiency (PE) in the control and treated experimental 
groups. (B): Colony formation in the control, 5-FU, PCA, and combination 
of 5-FU with PCA 
ap<0.05 vs. control cells, bp<0.05 vs. 5-FU treated cells, PE: Plating efficiency, 5-FU: 
5-fluorouracil, PCA: Protocatechuic acid, AGS: Gastric adenocarcinoma
Table 1. The viability percentage of the AGS cell line treated with 




Cell viability, % CI
5-FU (IC value) PCA (IC value)
1 5 (IC10) 600 (IC40) 39±4.4 0.72
2 10 (IC20) 500 (IC30) 20±2.7 0.60
3 20 (IC30) 400 (IC20) 45±4.1 0.81
4 30 (IC40) 200 (IC10) 45±2.9 0.79
AGS: Gastric adenocarcinoma, 5-FU: 5-fluorouracil, IC: Inhibitory concentration, 
PCA: Protocatechuic acid, CI: Combination index
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amplifies chemotherapy’s effects on tumor cells at lower 
concentrations but also it causes little toxicity to normal cells.25 
In the present study, the combined treatment of 5-FU with PCA 
had stronger antiproliferation effects than either agent alone 
(Figure 1). Several previous studies have shown that PCA alone 
can decrease cell proliferation and viability in some cancer cell 
lines such as breast, lung, liver, cervix, and prostate cancer 
cells,26,27 which is in line with the findings in the present study. 
On the other hand, many studies have demonstrated that the 
combination of natural compounds with chemotherapeutic 
drugs enhanced their antitumor efficacy through various 
mechanisms, including cell sensitization, induction of 
apoptosis, inhibition of cell proliferation, invasion, metastasis, 
and angiogenesis,28 which is in agreement with the findings 
of our study. It has been reported that natural compounds can 
disperse vimentin, an epithelial-mesenchymal transition factor, 
and cause loss of cytoplasmic integrity. These compounds can 
make changes in cellular morphology through destabilization of 
the nucleus, cytoskeleton, mitotic spindle, and cell flexibility.7,29 
Moreover, previous studies have shown that some antioxidants 
such as curcumin, resveratrol, and epigallocatechin-3-gallate 
not only have chemopreventive or chemotherapeutic effects 
but also they act as chemosensitizers on tumor cells.7,30-32 
Therefore, in the present study it seems that PCA, at least 
partly, sensitized the AGS tumor cells to 5-FU, which led to 
increased antiproliferation and cytotoxic efficiency of 5-FU. 
Our data demonstrated that the combined 5-FU and PCA 
resulted in a decrease in the number of colonies when compared 
to untreated control cells and each agent alone (Figure 2), 
which was in agreement with previous studies results.33,34 
A previous study showed that combined 5-FU, cisplatin, and 
curcumin enhanced the anticancer effects of 5-FU in human 
Figure 3. Induction of apoptosis after 24 h exposure to 5-FU (10 µM), PCA (500 µM), and combination of 5-FU and PCA (10 µM and 500 µM, respectively). 
Data were analyzed by FACScan and represent the mean of duplicate determinations. (A): Flow cytometry charts of Annexin V-FITC/PI staining in untreated 
(control) AGS cells and cells treated with 5-FU, PCA, and combination of 5-FU and PCA. (B): The percentage of apoptotic AGS cells. The results are 
expressed as mean ± SD of three separate experiments 
ap<0.05 vs. control cells, bp<0.05 vs. 5-FU treated cells 5-FU: 5-fluorouracil, PCA: Protocatechuic acid, AGS: Gastric adenocarcinoma, SD: Standard deviation
Figure 4. The gene expression of p53 in the presence or absence of 5-FU, 
PCA, and 5-FU/PCA combination on the AGS cells. Cells were exposed 
to a combination of 5-FU and PCA (10 µM and 500 µM, respectively). The 
expression of p53 was normalized with GAPDH as an internal standard
ap<0.05 vs. control cells, bp<0.05 vs. 5-FU treated cells
5-FU: 5-fluorouracil, PCA: Protocatechuic acid, AGS: Gastric adenocarcinoma, 
GAPDH: Glyceraldehyde-3-phosphate dehydrogenase
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gastric cancer MGC-803 cells by decreasing cell viability, 
inhibiting colony formation, and inducing apoptosis, which is in 
line with the present study findings.33 It has also been reported 
that glabridin, the major isoflavane in licorice root, may inhibit 
the malignant proliferation of the human gastric cancer MKN-
45 cell line and enhance the efficiency of 5-FU.34 The reduction 
in the number of colonies in the present study through 
combined 5-FU and PCA, at least partly, may have resulted 
from synergistic effects due to loss of sensitized cytoplasmic 
integrity and cellular changes such as Bcl-2 reduction, p53 
elevation, and cell morphology. 
Our flow cytometry results demonstrated that treatment with 
PCA and 5-FU combined resulted in increasing apoptosis in 
AGS cells compared to the untreated control cells (Figure 3). 
Antioxidants are used as anticancer compounds and can lead 
to cell death by activating the internal or external pathways of 
apoptosis.1 It has been demonstrated in several studies that 
PCA can induce apoptosis in cancer cells, which is in line with 
the results of the present study.35-37 In addition, PCA-induced 
apoptosis was found to be associated with the inhibition of 
Bcl-2, the mitochondrial translocation of Bax and Bid, and 
the cytosolic release of cytochrome C, which is in agreement 
with our study findings.38 On the other hand, it has been found 
that 5-FU induces apoptosis in cancer cells though p53.24,39-
41 It has also been reported that administration of 5-FU with 
troxerutin, a flavonoid, results in a dose-dependent suppression 
of cell proliferation and induces apoptosis, which is in line with 
our findings (Figures 1 and 3).42 In addition, it is reported that 
antioxidants can reduce the side effects and potential harmful 
impact of medications,43 influence multidrug resistance genes, 
which are responsible for resistance to different cytotoxic 
drugs, and enhance the residence time of chemotherapeutic 
drugs in cancer cells.7 Therefore, in the present study, the 
elevated efficacy of 5-FU for AGS apoptosis in the presence of 
PCA, at least partly, is due to PCA antioxidant capacity through 
sensitized cytoplasmic integrity and cellular changes such as 
Bcl-2 reduction and p53 elevation, and can trigger other internal 
or external signaling pathways of apoptosis. 
p53 acts as a transcription factor for a series of pro-apoptotic 
proteins (such as Bad, Bax, and Bid) and anti-apoptotic 
Bcl-2 signaling protein and induces apoptosis by releasing 
cytochrome C.44 Natural antioxidants can cause cell death by 
controlling members of the Bcl-2 family and promoting DNA 
damage.45 In addition, it has been demonstrated that Bcl-2, 
which encodes an inner mitochondrial protein, can antagonize 
apoptosis in many tumor cells.38 Our results showed that the 
combined 5-FU/PCA increased p53 gene expression and 
decreased cellular Bcl-2 signaling protein (Figures 4 and 
5). In many previous studies, it was found that PCA has the 
potential to induce apoptosis, increase p53 gene expression, 
and cause a decline in Bcl-2 protein, which is in agreement 
with our findings.38,46 Nevertheless, in the present study, it 
seems that the combination of PCA with 5-FU can strongly 
increase p53 gene expression (Figure 4). In another study, it 
was demonstrated that PCA acted as an apoptotic inducer of 
leukemia by decreasing the phosphorylation of retinoblastoma 
and decreasing the expression of Bcl-2, which is in line with 
the present study.38 On the other hand, researchers determined 
that Hibiscus polyphenol-rich extract containing PCA 
caused apoptosis in human gastric carcinoma cells via p53 
phosphorylation and the p38 MAPK/FasL cascade pathway.46 
In addition, it has been demonstrated that natural antioxidants 
such as forbesione, lupeol, luteolin, and myricetin can induce 
synergistic, apoptotic, and antiproliferative effects with 5-FU 
through the elevation of p53 gene expression and decreasing of 
the cellular Bcl-2 signaling protein in some cancer cells, which 
is in line with our findings.47-50 Therefore, in the present study, 
the elevation in p53 gene expression and the reduction in Bcl-2 
protein level in the presence of PCA, at least partly, may have 
resulted from the potential of PCA in cell sensitization to 5-FU 
by activating intracellular signaling pathways.
In the present study, we did not investigate the effects of the 
combined 5-FU/PCA treatment on other cellular signaling 
pathways such as FAK, MAPK, MMP, COX, JNK, Akt, ERK, 
Nf-кb, or caspases modulating factors, which influence 
invasion, metastasis, and apoptosis. We also did not study cell 
survival factors such as Bcl-xL or cFLIP. Thus, we suggest 
that prospective researchers investigate the above factors in 
combined 5-FU/PCA in future studies.
Figure 5. The Bcl-2 level of signaling pathway proteins in the AGS cell 
line. Cells were treated with 5-FU (10 µM), PCA (500 µM), and 5-FU/PCA 
combination (10 µM and 500 µM, respectively) for 24 h. (A): Density chart 
of Bcl-2/β-actin and (B): Western blots bands
ap<0.05 vs. control cells, bp<0.05 vs. 5-FU treated cells
Bcl-2: Bcl-2 protein 2, AGS: Gastric adenocarcinoma, 5-FU: 5-fluorouracil, PCA: 
Protocatechuic acid
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CONCLUSION
Our data indicate that the combined 5-FU/PCA treatment 
may promote antiproliferative and pro-apoptotic effects plus 
inhibition of colony formation in AGS cells. Some mechanisms 
by which the combined 5-FU/PCA treatment exerts its effects 
are associated with the upregulation of p53 and downregulation 
of Bcl-2 expression. Therefore, the combination of 5-FU with 
PCA not only could be a promising approach for potential 
reduction of dose requirements of 5-FU treatment but also 
could promote apoptosis via p53 and Bcl-2 signaling pathways. 
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